Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Etanercept Safe and Effective Long Term for Rheumatoid Arthritis
Link ID 30473
Title Etanercept Safe and Effective Long Term for Rheumatoid Arthritis
Url http://www.medscape.com/viewarticle/731799?src=rss
Description Treatment with etanercept (Enbrel) beyond 10 years is safe and effective for patients with early and long-standing rheumatoid arthritis (RA), according to findings published in the October 18th online Arthritis Care & Research. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Nov 4, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Women with Strong Thigh Muscles Protected from Symptomatic Knee Osteoarthritis
  Arthritis Care Research News Alerts
Category:   Articles > Rheumatology


2. Hypovitaminosis D Among Rheumatology Outpatients in Clinical Practice
  A role for vitamin D in the pathogenesis of autoimmune and inflammatory diseases is emerging. The authors undertook an audit of 25-hydroxyvitamin D (25OHD) investigation and treatment in rheumatology outpatients.
Rheumatology
Category:   Articles > Rheumatology


3. Cane Use May Reduce Risk of Knee Osteoarthritis Progression
  The aim of this study was to assess the immediate effects of walking shoes and a walking cane on the peak knee adduction moment in people with knee OA
Arthritis Care Research News Alerts
Category:   Articles > Rheumatology


4. Is Long-term Etanercept Therapy Safe and Effective in Patients With Juvenile Rheumatoid Arthritis?
  Juvenile rheumatoid arthritis can be difficult to treat, as not all traditional treatments are effective in patients. Can long-term etanercept therapy provide a safe and effective treatment option?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


5. Syk Kinase Inhibitor Rapidly Reduces Disease Activity in RA
  A new class of oral drugs for treatment of rheumatoid arthritis -- Syk kinase inhibitors -- produces a rapid reduction in disease activity, according to results of a phase II trial presented Monday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS